NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $40,125,000 | +82.8% | 1,709,729 | -4.4% | 0.03% | +83.3% |
| Q4 2016 | $21,946,000 | -30.8% | 1,788,352 | -3.2% | 0.02% | -33.3% |
| Q3 2016 | $31,723,000 | +7.6% | 1,846,526 | -10.9% | 0.03% | +8.0% |
| Q2 2016 | $29,481,000 | -1.6% | 2,071,804 | -4.9% | 0.02% | -3.8% |
| Q1 2016 | $29,960,000 | -25.0% | 2,178,797 | -8.0% | 0.03% | -23.5% |
| Q4 2015 | $39,921,000 | -20.7% | 2,369,215 | -48.4% | 0.03% | +47.8% |
| Q3 2015 | $50,340,000 | +122.1% | 4,593,096 | +153.5% | 0.02% | +21.1% |
| Q2 2015 | $22,664,000 | +38.4% | 1,811,704 | +21.7% | 0.02% | +46.2% |
| Q1 2015 | $16,374,000 | -16.4% | 1,488,524 | +17.9% | 0.01% | -23.5% |
| Q4 2014 | $19,575,000 | +37.3% | 1,262,900 | +6.9% | 0.02% | +30.8% |
| Q3 2014 | $14,255,000 | +8.7% | 1,181,048 | +15.5% | 0.01% | +8.3% |
| Q2 2014 | $13,114,000 | -2.6% | 1,022,959 | -7.9% | 0.01% | -7.7% |
| Q1 2014 | $13,464,000 | +26.4% | 1,110,928 | +18.4% | 0.01% | +30.0% |
| Q4 2013 | $10,651,000 | -1.3% | 938,376 | -9.1% | 0.01% | -9.1% |
| Q3 2013 | $10,786,000 | -30.2% | 1,032,134 | -22.9% | 0.01% | -31.2% |
| Q2 2013 | $15,456,000 | – | 1,338,178 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |